Daniel Kraciun

Dan leads marketing efforts and co-leads product design for Trust.med. His primary focuses are global market integration, communications, and tactical business operations. He brings a decades worth of experience in technical product design, research, and marketing. He is a graduate of Cleveland State University and is certified in GS1 standards for DSCSA suppliers.

DSCSA for Pharmacies: 3 Must Knows

DSCSA for Pharmacies: 3 Must Knows Data Exchange | Partner Verification | Tracing Requests January 17th, 2023 This is the year the pharmaceutical supply chain must comply with the FDA’s Drug Supply Chain Security Act (DSCSA). These requirements must be met in order to operate within the US Drug Supply Chain. As the primary touchpoint … Read more

The Drug Manufacturer’s DSCSA Dilemma

A decade’s worth of time has expired since the Drug Supply Chain Security Act (DSCSA) was passed to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. This November marks the start of the 12 month countdown requiring pharmaceutical trading partners to comply with the law. As time quickly slips away, trading partners are still left with unanswered questions and serious operational risks if found to be non-compliant by November 27, 2023.